Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2021 Jun;23(S2):S46-S68. doi: 10.1089/dia.2021.2504. Diabetes Technol Ther. 2021. PMID: 34061629 No abstract available.
New insulins and insulin therapy.
Danne T, Bolinder J. Danne T, et al. Among authors: bolinder j. Int J Clin Pract Suppl. 2012 Feb;(175):30-4. doi: 10.1111/j.1742-1241.2011.02851.x. Int J Clin Pract Suppl. 2012. PMID: 22308986 No abstract available.
Reimbursement for continuous glucose monitoring: a European view.
Heinemann L, Franc S, Phillip M, Battelino T, Ampudia-Blasco FJ, Bolinder J, Diem P, Pickup J, Hans Devries J. Heinemann L, et al. Among authors: bolinder j. J Diabetes Sci Technol. 2012 Nov 1;6(6):1498-502. doi: 10.1177/193229681200600631. J Diabetes Sci Technol. 2012. PMID: 23294797 Free PMC article.
New insulins and insulin therapy.
Danne T, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2013 Feb;15 Suppl 1:S40-7. doi: 10.1089/dia.2013.1505. Diabetes Technol Ther. 2013. PMID: 23441707 Review. No abstract available.
New insulins and insulin therapy.
Danne T, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S34-43. doi: 10.1089/dia.2014.1505. Diabetes Technol Ther. 2014. PMID: 24479598 No abstract available.
New insulins and insulin therapy.
Bolinder J, Danne T. Bolinder J, et al. Diabetes Technol Ther. 2015 Feb;17 Suppl 1:S39-46. doi: 10.1089/dia.2015.1505. Diabetes Technol Ther. 2015. PMID: 25679429 No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S43-55. doi: 10.1089/dia.2016.2505. Diabetes Technol Ther. 2016. PMID: 26836429 Review. No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2017 Feb;19(S1):S42-S58. doi: 10.1089/dia.2017.2505. Diabetes Technol Ther. 2017. PMID: 28192016 Review. No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505. Diabetes Technol Ther. 2018. PMID: 29437477 Review. No abstract available.
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M. Ólafsdóttir AF, et al. Among authors: bolinder j. Diabetes Technol Ther. 2018 Apr;20(4):274-284. doi: 10.1089/dia.2017.0363. Epub 2018 Apr 2. Diabetes Technol Ther. 2018. PMID: 29608107 Free PMC article. Clinical Trial.
199 results